ECSA/DPPA2, also known as CT100, is a human embryonic antigen that is predominantly expressed in NSCLC (Non-small cell lung carcinoma) and also in other malignancies including melanoma, lymphoma, and in lung, liver and colorectal cancers6,28. This evidence concerns the gene DPPA2 and non-small cell lung carcinoma.